tiprankstipranks
Trending News
More News >
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market

Lyell Immunopharma (LYEL) Ownership - Who Owns Lyell Immunopharma?

Compare
140 Followers

Lyell Immunopharma (LYEL) Ownership Overview

15.94%7.07%19.78%6.47%50.74%
15.94% Insiders
19.78% Other Institutional Investors
6.47% ETFs
50.74% Public Companies and Individual Investors
The ownership structure of Lyell Immunopharma (LYEL) stock is a mix of institutional, retail, and individual investors. Approximately 33.32% of the company’s stock is owned by Institutional Investors, 15.94% is owned by Insiders, and 50.74% is owned by Public Companies and Individual Investors.
The ownership structure of Lyell Immunopharma (LYEL) stock is a mix of institutional, retail, and individual investors. Approximately 26.85% of the company’s stock is owned by Institutional Investors, 15.94% is owned by Insiders, and 6.47% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 02, 2025
xxxxxxxxxxxxx
$19958
Mar 25, 2025
xxxxxxxxxxxxx
$114000
Mar 18, 2025
xxxxxxxxxxxxx
$110000
Mar 18, 2025
xxxxxxxxxxxxx
$105000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$33140

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,465,952Institution63.92%92,198,372
8,163,116Institution55.13%79,508,750
4,685,614Insider31.64%45,637,880
4,579,227Institution30.92%44,601,671
3,811,199Insider25.74%37,121,078
1,837,353Institution12.41%17,895,818
1,743,907Institution11.78%16,985,654
1,147,315Institution7.75%11,174,848
856,678Institution5.79%8,344,044
712,500Insider4.81%6,939,750

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
8,163,116Institution55.13%79,508,750
4,579,227Institution30.92%44,601,671
1,837,353Institution12.41%17,895,818
1,743,907Institution11.78%16,985,654
1,147,315Institution7.75%11,174,848
856,678Institution5.79%8,344,044
542,938Institution3.67%5,288,216
348,989Institution2.36%3,399,153
290,053Institution1.96%2,825,116
149,372Institution1.01%1,454,883

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,640,251Institution38.09%2,680,247
2,576,172Institution17.40%1,224,197
796,195Institution5.38%378,352
343,480Institution2.32%163,222
209,872Institution1.42%2,044,153
152,534Institution1.03%72,484
109,854Institution0.74%52,203
71,812Institution0.48%699,449
44,343Institution0.30%431,900
36,969Institution0.25%360,078

FAQ

Who Owns Lyell Immunopharma (LYEL)?
According to the latest TipRanks data, approximately 19.78% of the company's stock is held by institutional investors, 15.94% is held by insiders, and 50.74% is held by retail investors.
    What percentage of Lyell Immunopharma (LYEL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 19.78% of Lyell Immunopharma (LYEL) stock is held by institutional investors.
      What percentage of Lyell Immunopharma (LYEL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 50.74% of Lyell Immunopharma (LYEL) stock is held by retail investors.
        Who owns the most shares of Lyell Immunopharma (LYEL)?
        Vanguard owns the most shares of Lyell Immunopharma (LYEL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis